NXD-30001

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameNXD-30001
Drug Alias NameNXD-30001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeat shock protein HSP90 inhibitors
TargetsHeat shock protein HSP90
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTufts Medical Center Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTufts Medical Center Inc
Active IndicationsN/A
Inactive IndicationsGlioblastoma

Other Information

ATC CodeN/A
Related LinksN/A